Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Oct 15;51(5):805-9.
doi: 10.1002/art.20701.

Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma)

Lisa M Brower  1 , Janet L Poole
Affiliations

Reliability and validity of the Duruoz Hand Index in persons with systemic sclerosis (scleroderma)

Lisa M Brower et al. Arthritis Rheum. .

Erratum in

  • Arthritis Rheum. 2005 Apr 15;53(2):303

Abstract

Objective: To examine the test-retest reliability and concurrent validity of the Duruoz Hand Index (DHI) in persons with scleroderma.

Methods: Forty patients with scleroderma and no other major medical problems completed the DHI at 2 points in time to assess test-retest reliability. To assess validity, participants were administered the Arthritis Hand Function Test (AHFT), the Hand Mobility in Scleroderma Test (HAMIS), and the Keital Function Test (KFT), all performance-based tests. In addition, participants completed the Health Assessment Questionnaire (HAQ), a self report of functional ability.

Results: Test-retest reliability intraclass correlation coefficients for the DHI ranged from 0.81 to 0.97. Scores on the DHI did not correlate with HAMIS scores, but were significantly correlated with scores from the KFT (rs = 0.48, P < 0.01), HAQ (rs = 0.79, P < 0.01), and all sections of the AHFT (rs = 0.34-0.60, P < 0.05-0.01).

Conclusion: The results from this study show the DHI to be a reliable and valid test for persons with scleroderma.

PubMed Disclaimer

Publication types